Literature DB >> 22128166

Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.

Umeharu Ohto1, Kimihito Usui, Toshinari Ochi, Kenjiro Yuki, Yoshinori Satow, Toshiyuki Shimizu.   

Abstract

G(M1) gangliosidosis and Morquio B are autosomal recessive lysosomal storage diseases associated with a neurodegenerative disorder or dwarfism and skeletal abnormalities, respectively. These diseases are caused by deficiencies in the lysosomal enzyme β-d-galactosidase (β-Gal), which lead to accumulations of the β-Gal substrates, G(M1) ganglioside, and keratan sulfate. β-Gal is an exoglycosidase that catalyzes the hydrolysis of terminal β-linked galactose residues. This study shows the crystal structures of human β-Gal in complex with its catalytic product galactose or with its inhibitor 1-deoxygalactonojirimycin. Human β-Gal is composed of a catalytic TIM barrel domain followed by β-domain 1 and β-domain 2. To gain structural insight into the molecular defects of β-Gal in the above diseases, the disease-causing mutations were mapped onto the three-dimensional structure. Finally, the possible causes of the diseases are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22128166      PMCID: PMC3265862          DOI: 10.1074/jbc.M111.293795

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  UniProt: the Universal Protein knowledgebase.

Authors:  Rolf Apweiler; Amos Bairoch; Cathy H Wu; Winona C Barker; Brigitte Boeckmann; Serenella Ferro; Elisabeth Gasteiger; Hongzhan Huang; Rodrigo Lopez; Michele Magrane; Maria J Martin; Darren A Natale; Claire O'Donovan; Nicole Redaschi; Lai-Su L Yeh
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

3.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

4.  Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme.

Authors:  A van der Spoel; E Bonten; A d'Azzo
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

5.  Structural comparisons of TIM barrel proteins suggest functional and evolutionary relationships between beta-galactosidase and other glycohydrolases.

Authors:  D H Juers; R E Huber; B W Matthews
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

Review 6.  Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.

Authors:  J W Callahan
Journal:  Biochim Biophys Acta       Date:  1999-10-08

7.  Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactose.

Authors:  A L Rojas; R A P Nagem; K N Neustroev; M Arand; M Adamska; E V Eneyskaya; A A Kulminskaya; R C Garratt; A M Golubev; I Polikarpov
Journal:  J Mol Biol       Date:  2004-11-05       Impact factor: 5.469

8.  Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease.

Authors:  Toshika Okumiya; Hitoshi Sakuraba; Ryoichi Kase; Tetsuro Sugiura
Journal:  Mol Genet Metab       Date:  2003-01       Impact factor: 4.797

9.  Human placental beta-galactosidase. Characterization of the dimer and complex forms of the enzyme.

Authors:  M Hubbes; R M D'Agrosa; J W Callahan
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

10.  Trimeric crystal structure of the glycoside hydrolase family 42 beta-galactosidase from Thermus thermophilus A4 and the structure of its complex with galactose.

Authors:  Masafumi Hidaka; Shinya Fushinobu; Naomi Ohtsu; Hidemasa Motoshima; Hiroshi Matsuzawa; Hirofumi Shoun; Takayoshi Wakagi
Journal:  J Mol Biol       Date:  2002-09-06       Impact factor: 5.469

View more
  41 in total

1.  Structural insights into the substrate specificity of Streptococcus pneumoniae β(1,3)-galactosidase BgaC.

Authors:  Wang Cheng; Lei Wang; Yong-Liang Jiang; Xiao-Hui Bai; Jun Chu; Qiong Li; Ge Yu; Qiu-Ling Liang; Cong-Zhao Zhou; Yuxing Chen
Journal:  J Biol Chem       Date:  2012-05-16       Impact factor: 5.157

2.  Expression, purification, crystallization and preliminary X-ray crystallographic analysis of tomato β-galactosidase 4.

Authors:  Masahiro Eda; Megumi Ishimaru; Toshiji Tada
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

3.  β-Galactosidosis in Patient with Intermediate GM1 and MBD Phenotype.

Authors:  Tereza Moore; Jonathan A Bernstein; Sylvie Casson-Parkin; Tina M Cowan
Journal:  JIMD Rep       Date:  2012-04-22

4.  Crystallization and preliminary X-ray diffraction data of β-galactosidase from Aspergillus niger.

Authors:  Agustín Rico-Díaz; Ángel Vizoso Vázquez; M Esperanza Cerdán; Manuel Becerra; Julia Sanz-Aparicio
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-10-25       Impact factor: 1.056

5.  The skeletal phenotype of intermediate GM1 gangliosidosis: Clinical, radiographic and densitometric features, and implications for clinical monitoring and intervention.

Authors:  Carlos R Ferreira; Debra S Regier; Robin Yoon; Kristen S Pan; Jean M Johnston; Sandra Yang; Jürgen W Spranger; Cynthia J Tifft
Journal:  Bone       Date:  2019-11-06       Impact factor: 4.398

6.  Clinical and molecular characteristics of 11 Chinese probands with GM1 gangliosidosis.

Authors:  Yuyu Feng; Yonglan Huang; Xiaoyuan Zhao; Huiying Sheng; Yi Feng; Wen Zhang; Li Liu
Journal:  Metab Brain Dis       Date:  2018-09-28       Impact factor: 3.584

7.  SAAMP 2.0: An algorithm to predict genotype-phenotype correlation of lysosomal storage diseases.

Authors:  L Ou; M J Przybilla; C B Whitley
Journal:  Clin Genet       Date:  2018-03-05       Impact factor: 4.438

8.  Induced Structural Disorder as a Molecular Mechanism for Enzyme Dysfunction in Phosphoglucomutase 1 Deficiency.

Authors:  Kyle M Stiers; Bailee N Kain; Abigail C Graham; Lesa J Beamer
Journal:  J Mol Biol       Date:  2016-03-10       Impact factor: 5.469

9.  Pharmacological chaperones for human α-N-acetylgalactosaminidase.

Authors:  Nathaniel E Clark; Matthew C Metcalf; Daniel Best; George W J Fleet; Scott C Garman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

10.  A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.

Authors:  Tomoko Takai; Katsumi Higaki; Matilde Aguilar-Moncayo; Teresa Mena-Barragán; Yuki Hirano; Kei Yura; Liang Yu; Haruaki Ninomiya; M Isabel García-Moreno; Yasubumi Sakakibara; Kousaku Ohno; Eiji Nanba; Carmen Ortiz Mellet; José M García Fernández; Yoshiyuki Suzuki
Journal:  Mol Ther       Date:  2013-01-22       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.